October 12, 2018
Distinguished Alumna Address - Mark Rampy, Ph.D., MBA
12:00 PM
2901 THSL
Mark Rampy, Ph.D. (1995, Counsell lab), MBA, Chief Business Officer, Sequella, Inc.
"Use of T-Cells as Therapeutics: Developing “Tailored” Immunotherapies for the Treatment of Cancer"